Literature DB >> 23690121

Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia.

Annikka Weissferdt1, Alexandria Phan, Saul Suster, Cesar A Moran.   

Abstract

Adrenocortical carcinomas (ACCs) with myxoid features are rare neoplasms. We identified 7 cases of myxoid ACC and studied the clinicopathologic and immunohistochemical features of these neoplasms. The patients were 5 men and 2 women with a mean age of 45 years. Histologically, the tumors contained alcian blue-positive myxoid areas ranging from 10% to 50% of the tissue examined. One case showed lipomatous metaplasia. Areas of conventional ACC were present in all cases. Immunohistochemically, the tumors were positive for steroid receptor cofactor 1, inhibin, melan A, calretinin, and synaptophysin but negative for high-molecular-weight cytokeratin, CAM5.2, and Pax8. Clinical follow-up information for 4 patients demonstrated that all patients had died of their disease 11 to 69 months after diagnosis. Myxoid ACCs are rare tumors that expand the differential diagnosis of myxoid neoplasms involving the retroperitoneum. Contrary to previous reports proposing that the biologic behavior is similar to conventional ACC, our series seems to indicate that myxoid morphology is associated with more aggressive behavior.

Entities:  

Keywords:  Adrenocortical carcinoma; Endocrine tumor; Immunohistochemistry; Myxoid change

Mesh:

Substances:

Year:  2013        PMID: 23690121     DOI: 10.1309/AJCPCDZLC13RSXRZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors.

Authors:  Mauro Papotti; Eleonora Duregon; Marco Volante; Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

2.  Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.

Authors:  Hongmei Li; Ondrej Hes; Gregory T MacLennan; Daniel C Eastwood; Kenneth A Iczkowski
Journal:  Virchows Arch       Date:  2015-02-19       Impact factor: 4.064

Review 3.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

4.  Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.

Authors:  Tae Yon Sung; Yun Mi Choi; Won Gu Kim; Yu Mi Lee; Tae Yong Kim; Young Kee Shong; Won Bae Kim; Dong Eun Song
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

Review 5.  Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Authors:  Alfred King-Yin Lam
Journal:  Biomedicines       Date:  2021-02-10

6.  Adrenocortical neoplasm of uncertain malignant potential with a myelolipomatous component.

Authors:  Adithya Balasubramanian; Jason Scovell; Adam E Dowell; Wesley Mayer
Journal:  BMJ Case Rep       Date:  2020-06-11

7.  Robot-Assisted Laparoscopic Adrenalectomy for Rare Myxoid Adrenocortical Carcinoma.

Authors:  Grant Johnson; Kiran Thalody; Umesh Kapur; Thai T Nguyen
Journal:  Case Rep Urol       Date:  2019-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.